LGP.AX ASX
Little Green Pharma Ltd
1W: -2.8%
1M: +9.4%
3M: +2.9%
YTD: -42.6%
1Y: -46.1%
3Y: -57.6%
5Y: -90.5%
A$0.07 ($0.05)
-0.00 (-2.86%)
Weekly Expected Move ±8.3%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$42M
+15.2% ▲
5Y CAGR: +80.7%
Gross Profit
$12M
-53.6% ▼
5Y CAGR: +59.0%
Operating Income
-$2M
+51.6% ▲
Net Income
-$1M
-142.4% ▼
EPS (Diluted)
$-0.00
-141.8% ▼
EBITDA
$2M
+370.3% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $7M | $14M | $20M | $37M | $42M |
| YoY Growth | +217.8% | +100.5% | +39.4% | +0.0% | +15.2% |
| Cost of Revenue | $1M | $10M | $8M | $12M | $31M |
| Gross Profit | $6M | $5M | $12M | $25M | $12M |
| Gross Margin | 82.5% | 32.1% | 61.2% | 68.6% | 27.6% |
| R&D Expenses | $2M | $7M | $7M | $290K | $46K |
| SG&A Expenses | $6M | $26M | $8M | $24M | $22M |
| Operating Expenses | $11M | $33M | $25M | $25M | $14M |
| Operating Income | $25M | -$28M | -$8M | -$4M | -$2M |
| Operating Margin | 352.6% | -202.1% | -39.0% | -11.0% | -4.6% |
| Interest Expense | $92K | $725K | $929K | $384K | $553K |
| Income Before Tax | $25M | -$27M | -$9M | -$5M | -$2M |
| Tax Expense | $29M | -$3M | $4M | -$8M | -$136K |
| Net Income | -$4M | -$24M | -$9M | $3M | -$1M |
| Net Margin | -62.2% | -171.4% | -47.0% | 9.0% | -3.3% |
| EPS (Diluted) | $-0.03 | $-0.10 | $-0.04 | $0.01 | $-0.00 |
| EBITDA | $25M | -$27M | -$5M | -$684K | $2M |
| Shares Outstanding | 166M | 236M | 250M | 302M | 305M |